XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML

Bing Z. Carter, Duncan H. Mak, Stephen J. Morris, Gautam Borthakur, Elihu Estey, Anna L. Byrd, Marina Konopleva, Hagop Kantarjian, Michael Andreeff

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds